Alkalinization
Analgesics..
Antiandrogens..
Bromhexine
Budesonide
Cannabidiol
Colchicine
Conv. Plasma
Curcumin
Ensovibep
Famotidine
Favipiravir
Fluvoxamine
Hydroxychlor..
Iota-carragee..
Ivermectin
Lactoferrin
Lifestyle..
Melatonin
Metformin
Molnupiravir
Monoclonals..
Nigella Sativa
Nitazoxanide
Nitric Oxide
Paxlovid
Peg.. Lambda
Povidone-Iod..
Quercetin
Remdesivir
Vitamins..
Zinc

Other
Feedback
Home
Home   COVID-19 treatment studies for Bromhexine  COVID-19 treatment studies for Bromhexine  C19 studies: Bromhexine  Bromhexine   Select treatmentSelect treatmentTreatmentsTreatments
Alkalinization Meta Lactoferrin Meta
Melatonin Meta
Bromhexine Meta Metformin Meta
Budesonide Meta Molnupiravir Meta
Cannabidiol Meta
Colchicine Meta Nigella Sativa Meta
Conv. Plasma Meta Nitazoxanide Meta
Curcumin Meta Nitric Oxide Meta
Ensovibep Meta Paxlovid Meta
Famotidine Meta Peg.. Lambda Meta
Favipiravir Meta Povidone-Iod.. Meta
Fluvoxamine Meta Quercetin Meta
Hydroxychlor.. Meta Remdesivir Meta
Iota-carragee.. Meta
Ivermectin Meta Zinc Meta

Other Treatments Global Adoption
All Studies   Meta Analysis   Recent:  
The potential role of Bromhexine in the management of COVID-19: Decipher and a real game-changer
Al-Kuraishy et al., Current Medical and Drug Research (Review) (Preprint)
Al-Kuraishy et al., The potential role of Bromhexine in the management of COVID-19: Decipher and a real game-changer, Current Medical and Drug Research (Review) (Preprint)
Dec 2020   Source   PDF  
  Twitter
  Facebook
Share
  All Studies   Meta
Review article noting that bromhexine is a TMPRSS2 inhibitor with greater effect in lung tissue and attenuates the entry and proliferation of SARS-CoV-2.
Al-Kuraishy et al., 31 Dec 2020, preprint, 5 authors.
All Studies   Meta Analysis   Submit Updates or Corrections
This PaperBromhexineAll
Abstract: See discussions, stats, and author profiles for this publication at: https://www.researchgate.net/publication/347446399 The potential role of Bromhexine in the management of COVID-19: Decipher and a real game-changer Article · December 2020 DOI: 10.4103/2305- CITATIONS READS 0 2,112 5 authors, including: Hayder Al-kuraishy Ali Ismail Al-Gareeb Al-Mustansiriyah University Al-Mustansiriya University 262 PUBLICATIONS 1,379 CITATIONS 211 PUBLICATIONS 1,267 CITATIONS SEE PROFILE SEE PROFILE Claire Lugnier University of Strasbourg 197 PUBLICATIONS 6,627 CITATIONS SEE PROFILE Some of the authors of this publication are also working on these related projects: Salivary nitrite levels in patients with T2DM: effect of diabetic pharmacotherapy View project Purification and molecular characterization of cardiovascular phosphodiesterase isoenzymes View project All content following this page was uploaded by Hayder Al-kuraishy on 18 December 2020. The user has requested enhancement of the Curr Med Drug Res, 2021, 5 (1), Article ID 212 Concept note The potential role of Bromhexine in the management of COVID-19: Decipher and a real game-changer Hayder M. Al-Kuraishy1,*, Marwa S. Al-Niemi2, Nawar R. Hussain2, Ali I. Al-Gareeb1 and Claire Lugnier3,* 1 Department of Clinical Pharmacology, Medicine and Therapeutics, College of Medicine, Al-Mustansiriya University, P.O. Box 14132, Baghdad, Iraq 2 Department of Pharmacology, College of Pharmacy, Al-Farahidi University, P.O. Box 14132, Baghdad, Iraq 3 Unistra, Faculté de Médecine, Institut de Physiologie, EA 3072 “Mitochondrie, stress oxydant et protection musculaire”, 4 Rue Kirschleger, 67085, Strasbourg Cedex, France *Corresponding authors. E-mail: hayderm36@yahoo.com (HMA); claire.lugnier@unistra.fr (CL); Phone: +96407906230487 Article history Received : December 06, 2020 Accepted : December 18, 2020 Keywords Bromhexine COVID-19 Novel coronavirus SARS‐CoV‐2 TMPRSS2 ABSTRACT Primary infection of SARS‐CoV‐2 (novel coronavirus or 2019‐nCoV), which leads to Covid-19, targets specific cells, such as nasal, bronchial epithelial and pneumocytes, through the viral structural spike (S) protein that binds to the angiotensin-converting enzyme 2 (ACE2) receptor. Also, type 2 transmembrane serine protease (TMPRSS2) present in the host cell promotes viral uptake by cleaving ACE2 and triggering the SARS-CoV-2 S protein, which facilitates SARS-CoV-2 entry into host cells. One of the TMPRSS2 inhibitors with a greater distribution capacity into the lung tissue is bromhexine hydrochloride which attenuates the entry and proliferation of SARS‐CoV‐2. Bromhexine is an effective drug in the management and treatment of Covid-19 pneumonia via targeting ACE2/ TMPRSS2 pathway. However, prospective and controlled clinical trials are recommended to confirm this observation. © 2021 Global SciTech Ocean Publishing Co. All rights reserved. ISSN. 2581-5008
Loading..
Please send us corrections, updates, or comments. Vaccines and treatments are complementary. All practical, effective, and safe means should be used based on risk/benefit analysis. No treatment, vaccine, or intervention is 100% available and effective for all current and future variants. We do not provide medical advice. Before taking any medication, consult a qualified physician who can provide personalized advice and details of risks and benefits based on your medical history and situation. FLCCC and WCH provide treatment protocols.
  or use drag and drop   
Submit